Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients

Transpl Int. 2022 Jan 4:35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.

Authors

Maria C Haller^{1

2}, Robert A Kaiser¹, Simon Langthaler¹, Clara Brandstetter¹, Petra Apfalter³, Heidrun Kerschner³, Daniel Cejka¹

Affiliations

¹ Internal Medicine III-Nephrology, Transplantation Medicine, Rheumatology, Ordensklinikum, Linz, Austria.
² Section for Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
³ Institute for Hygiene, Microbiology and Tropical Medicine, Ordensklinikum, Linz, Austria.

No abstract available

Keywords: Covid-19; Sars-CoV-2; kidney transplantation; mRNA vaccine; vaccination.

Publication types

Letter

MeSH terms

2019-nCoV Vaccine mRNA-1273
Antibodies, Viral
BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Humans
Kidney Transplantation*
SARS-CoV-2
Transplant Recipients
Vaccines, Synthetic
mRNA Vaccines

Substances

Antibodies, Viral
COVID-19 Vaccines
Vaccines, Synthetic
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine